usecure erhält auf der Beyond 2025 die Auszeichnung „Most Valuable Vendor – EMEA” von Pax8
MANCHESTER, England, 30. Juni 2025 /PRNewswire/ — usecure, die führende Lösung für das Management menschlicher Risiken für MSPs und interne IT-Teams, wurde auf der Pax8 Beyond 2025, die Anfang dieses Monats in Denver, Colorado, stattfand, als „Most Valuable Vendor – EMEA” ausgezeichnet. Continue Reading usecure proudly received the Most Valuable Vendor (EMEA) award at Pax8 […]
usecure remporte le prix Pax8 « Most Valuable Vendor – EMEA » lors de la conférence Beyond 2025
MANCHESTER, Angleterre, 30 juin 2025 /PRNewswire/ — usecure, la principale solution de gestion des risques humains pour les MSP et les équipes informatiques internes, a été nommée « Most Valuable Vendor – EMEA » lors de la conférence Pax8 Beyond 2025, qui s’est tenue au début du mois à Denver, dans le Colorado. Continue Reading […]
usecure Wins Pax8 ‘Most Valuable Vendor – EMEA’ Award at Beyond 2025
MANCHESTER, England, June 30, 2025 /PRNewswire/ — usecure, the leading human risk management solution for MSPs and internal IT teams, has been named ‘Most Valuable Vendor – EMEA‘ at Pax8 Beyond 2025, held earlier this month in Denver, Colorado. The prestigious award recognises usecure’s outstanding contribution to supporting MSP partners across the EMEA region. It […]
ATRenew Releases 2024 ESG Report: Painting a New Picture of Sustainable Development
SHANGHAI, June 30, 2025 /PRNewswire/ — ATRenew Inc. (“ATRenew” or the “Company”) (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform in China, today released its 2024 Environmental, Social and Governance (ESG) Report. The report highlights ATRenew’s progress and achievements in green recycling, low-carbon transition, corporate governance, and technological innovation, demonstrating the […]
usecure Wins Pax8 ‘Most Valuable Vendor – EMEA’ Award at Beyond 2025
MANCHESTER, England, June 30, 2025 /PRNewswire/ — usecure, the leading human risk management solution for MSPs and internal IT teams, has been named ‘Most Valuable Vendor – EMEA’ at Pax8 Beyond 2025, held earlier this month in Denver, Colorado. The prestigious award recognises usecure’s outstanding contribution to supporting MSP partners across the EMEA region. It marks […]
LGHL Reaches $5 Million in HYPE, SOL, and SUI Purchases for Treasury Reserve
SINGAPORE, June 30, 2025 /PRNewswire/ — Lion Group Holding Ltd. (Nasdaq: LGHL) (“LGHL” or the “Company”) today announced that the Company has reached approximately $5 million in combined purchases of HYPE, SOL and SUI for its next-generation layer-1s treasury reserve. Treasury holdings as of June 30, 2025: Hyperliquid (HYPE): 79,775 tokens Solana (SOL): 6,629 tokens […]
CME Group to Launch FX Tape+ to Provide Centralized Reference Prices for the FX Market
CHICAGO and LONDON, June 30, 2025 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that it will launch CME FX Tape+ to provide centralized reference prices and a comprehensive view of FX market liquidity from its transparent central limit order book (CLOB) marketplaces, including FX futures, EBS Market, FX Spot+ and FX Link. […]
PlaDeo: Europe Debut for the World’s First Bio-Plasma Powered Deodorant Device
CES Award-Winning Korean Innovation Now Targets EU Consumers Seeking Safe and Sustainable Hygiene SEOUL, South Korea, June 30, 2025 /PRNewswire/ — CodeSteri Inc., a bio-tech startup born out of Hanyang University College of Medicine, is expanding into Europe with PlaDeo — the world’s first electronic deodorant device powered by bio-plasma. Following a strong reception in the […]
SPS Survey on Theaters and Concert Halls in Japan Shows Growing Interest among Foreign Visitors in Japanese Performances
TOKYO, June 30, 2025 /PRNewswire/ — Suntory Publicity Service Ltd. (hereinafter “SPS”), which operates and provides consulting services for cultural and corporate facilities, has announced the results of its survey on the usage of Japanese theaters and concert halls by foreign visitors to Japan. Survey overview: https://kyodonewsprwire.jp/attach/202506170689-O2-52mMq2T2.pdf The survey covered 750 people from South Korea, […]
ESTEVE to acquire medicine to treat medullary thyroid cancer
Caprelsa® (vandetanib) is a medicine that is used in adults and children above 5 years of age to treat aggressive and symptomatic medullary thyroid cancer1. This is a new step forward in ESTEVE’s international growth journey focused on highly specialized treatments for high unmet medical and patient needs. BARCELONA, Spain, June 30, 2025 /PRNewswire/ — […]